Appropriations bill
This article was originally published in The Tan Sheet
Executive Summary
A resolution to the Agriculture, Rural Development, FDA & Related Agencies Appropriations bill for fiscal 2006 mandates that members of FDA advisory committees disclose conflicts of interest no later than 15 days prior to meetings in order to receive waivers, according to a House conference report issued Oct. 28. Congress approved a measure by Rep. Maurice Hinchey (D-N.Y.) in June that would have stopped funding for waivers, thus preventing scientists and doctors with conflicts of interest from participating on committees (1"The Tan Sheet" June 13, 2005, p. 10). The Senate revamped the language in September to approve a less stringent measure; the Senate language serves as the foundation for the conference version, which "says to the FDA...if you want to continue using doctors and scientists with conflicts of interest, go right ahead, just let us know about it," Hinchey said. "That's unacceptable"...
You may also be interested in...
FDA Panel Conflict of Interest Waivers Would Be Barred Under House Bill
FDA would effectively be barred from granting financial conflict of interest waivers for advisory committee members under the fiscal year 2006 House agriculture appropriations bill
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.